Summary
この調査レポートでは、2010年から2022年の電子皮膚パッチ市場の履歴データ、2023年から2033年の電子皮膚パッチ市場の予測を掲載しております。
主な掲載内容（目次より抜粋）
-
皮膚貼付剤による糖尿病管理
-
心拍モニタリング用皮膚パッチ
-
一般患者モニタリング用皮膚パッチ
-
温度感知皮膚パッチ
-
皮膚パッチによる電気刺激
-
イオントフォレーシス皮膚パッチ
-
汗感知皮膚パッチ
-
その他の電子皮膚パッチアプリケーション
-
電子皮膚パッチの製造
-
市場予測
-
会社概要
Report Summary
This report characterizes the markets, technologies, and players in electronic skin patches. With coverage across 13 application areas, historic electronic skin patch market data from 2010-2022 and electronic skin patch market forecasts from 2023 to 2033, it is the most comprehensive study compiled for this product area. It reveals significant opportunity, with the electronic skin patch market forecast to grow to over US$27B by 2033.
Electronic skin patches are wearable products attached to the skin. The electronic element involves the integration of electronic functionality such as sensors, actuators, processors, and communication, allowing products to become connected and "smart". In many ways, electronic skin patches act as the ultimate wearable electronic devices, augmenting the wearer with minimal encumbrance and maximum comfort. As such, interest in electronic skin patches soared as a by-product of the significant hype and market growth around "wearables" starting in 2014.
However, several product types within the sector transcend this hype. Electronic skin patch product areas in diabetes management and cardiac rhythm monitoring have superseded incumbent options in established markets to create billions of dollars of new revenue each year for the companies at the forefront of this wave. However, success is not ubiquitous; each market discussed within this report sits within a unique ecosystem, with different players, drivers, limitations, and history to build on.
As such, the report looks at each of the application areas for electronic skin patches in turn, discussing the relevant technology, product types, competitive landscape, industry players, pricing, historic revenue, and electronic skin patch market forecasts. The areas covered include diabetes management (CGM and insulin pumps), cardiovascular monitoring devices (MCT, Holter monitors, and event monitors), general patient monitoring (both inpatient and outpatient), temperature sensing, drug and cosmetic delivery patches, electrical stimulation devices, sweat sensing, and other emerging options such as wound care, motion sensing, and more. The report also discusses manufacturing of electronic skin patches, including focus on emerging material options as well as the technology underlying the manufacturing process. The report contains historic revenue data for each of the product sectors studied back to 2010, including data by company for the larger sectors. The report also contains detailed market forecasting over 10 years for each of the key application areas.
(2).png)
Source: Electronic Skin Patches 2023-2033
The research behind the report has been compiled over several years by IDTechEx analysts. It follows existing coverage of areas such as wearable technology, flexible electronics, stretchable and conformal electronics, electronic textiles, advanced wound care, bioelectronics, cardiovascular diseases, diabetes, sensors, and other medical devices. The methodology involved a mixture of primary and secondary research, with a key focus on speaking to executives and scientists from companies developing commercial electronic skin patches. As such, the report analyses over 130 companies and projects, both current and historic, including over 40 profiles and case studies.
Unique position and experience behind the report
IDTechEx is afforded a particularly unique position in covering this topic. The analyst team builds on decades of experience covering emerging technology markets, and particularly areas, such as flexible electronics, which are central to electronic skin patches. This has been historically supported by IDTechEx's parallel activities in organising the leading industry conferences and exhibitions covering flexible and wearable electronics, as well as smaller events covering specific innovation trends such as for healthcare sensors or related areas. IDTechEx has the unique ability to curate a network in these topic areas, facilitating the analysis in this report.
This report provides critical market intelligence about the product sector and each of the 13 electronic skin patch application sectors involved. This includes:
A review of the context and technology behind electronic skin patch products:
-
History and context for the product area and each subsector
-
General overview of important technologies within each sector
-
Overall look at electronic skin patches trends and themes within the product area
-
Benchmarking and analysis of different players throughout
Full market characterization for each major electronic skin patch product:
-
Review of the diabetes management landscape, including historical context, the rise of CGM, development of insulin pumps and patch pumps, closed loop systems and development towards non-invasive glucose monitoring
-
Review of the ecosystem for cardiovascular skin patches, including their context within competitive products, the differentiation within the sector (e.g. Holter, Event, Extended Holter, and MCT), and the reimbursement and funding scenario.
-
Vital sign monitoring more generally, including technology and business model reviews across players in the industry and the growing use in clinical trials
-
Reviews of other niche sectors, including various temperature monitoring use cases, iontophoresis, electrical stimulation and more
Market analysis throughout:
-
Reviews of electronic skin patch players throughout each key sector, analyzed from over 130 companies
-
Historic electronic skin patch market data from 2010-2022 for 11 sectors
-
Market forecasts from 2023-2033 for 13 sectors, including full narrative, limitations, and methodologies for each
Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldRephraseRephrase current sentenceEdit in Ginger
Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldRephraseRephrase current sentenceEdit in Ginger
Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldRephraseRephrase current sentenceEdit in Ginger
Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldRephraseRephrase current sentenceEdit in Ginger
ページTOPに戻る
Table of Contents
Enable Ginger
|
1. |
EXECUTIVE SUMMARY |
|
1.1. |
Scope of the report |
|
1.2. |
Benefits of electronic skin patches as a form factor |
|
1.3. |
Market push and pull drivers |
|
1.4. |
Skin patch applications overview |
|
1.5. |
Diabetes management devices: electronic skin patches increase patient comfort |
|
1.6. |
Diabetes management device roadmap: Glucose sensors |
|
1.7. |
Key points for diabetes management devices: continuous glucose monitoring |
|
1.8. |
Diabetes management device roadmap: Insulin delivery |
|
1.9. |
Key points for diabetes management devices: insulin delivery |
|
1.10. |
Atrial fibrillation: electronic skin patches addresses key industry pain points |
|
1.11. |
Diagnosis process for atrial fibrillation and other arrhythmias |
|
1.12. |
Key points for cardiac monitoring: Holter, mobile cardiac telemetry & event monitor |
|
1.13. |
Vital sign monitoring: electronic skin patches increase patient mobility |
|
1.14. |
Emerging application: Decentralized clinical trials |
|
1.15. |
Key points for general vital sign monitoring |
|
1.16. |
Other applications: temperature, electrical stimulation, iontophoresis and sweat sensing |
|
1.17. |
Electronic skin patch manufacturing process |
|
1.18. |
Material requirements for an electronic skin patch |
|
1.19. |
Electronic skin patches global market annual revenue historic data and forecast 2010-2033 |
|
1.20. |
Electronic skin patches global market annual revenue forecast 2022-2033 |
|
2. |
INTRODUCTION |
|
2.1. |
How to use this report |
|
2.2. |
Definitions |
|
2.3. |
The case for skin patches: augmenting the human body |
|
2.4. |
Electronic skin patches within wearable technology progress |
|
2.5. |
Benefits of electronic skin patches as a form factor |
|
2.6. |
Market push and pull drivers |
|
2.7. |
Key milestones in the history of skin patches |
|
2.8. |
COVID-19 effect on electronic skin patches |
|
2.9. |
Privacy and IT challenges |
|
2.10. |
Reimbursement drives commercial business models |
|
2.11. |
Reimbursement codes (US) |
|
2.12. |
Skin patch applications overview |
|
2.13. |
Skin patch applications overview |
|
2.14. |
Skin patch applications overview |
|
3. |
DIABETES MANAGEMENT VIA SKIN PATCHES |
|
3.1.1. |
Background: Introduction to diabetes |
|
3.1.2. |
The prevalence of diabetes |
|
3.1.3. |
Diabetes management ecosystem |
|
3.1.4. |
Background: Diabetes on the rise |
|
3.1.5. |
Diabetes management device roadmap: Summary |
|
3.1.6. |
Electronic skin patches in diabetes management: company profiles |
|
3.2. |
Continuous glucose monitoring |
|
3.2.1. |
Diabetes management device roadmap: Glucose sensors |
|
3.2.2. |
Continuous glucose monitors (CGMs) take the form of skin patches |
|
3.2.3. |
CGMs are superseding test strips |
|
3.2.4. |
CGM reimbursement for type 2 is currently limited |
|
3.2.5. |
CGM usage in hospitals |
|
3.2.6. |
Anatomy of a typical CGM device |
|
3.2.7. |
CGM: Technology |
|
3.2.8. |
CGM sensor manufacturing and anatomy |
|
3.2.9. |
Comparison metrics for CGM devices |
|
3.2.10. |
Example: Accuracy of CGM devices over time |
|
3.2.11. |
CGM: Overview of key players |
|
3.2.12. |
Abbott Laboratories: CGM business |
|
3.2.13. |
Dexcom: Introduction |
|
3.2.14. |
Medtronic: Introduction |
|
3.2.15. |
Ascensia, POCTech and Yuwell |
|
3.2.16. |
Senseonics |
|
3.2.17. |
Non-invasive glucose monitoring |
|
3.2.18. |
Conclusions for continuous glucose monitors |
|
3.2.19. |
Insulin pumps |
|
3.2.20. |
Insulin delivery: Introduction |
|
3.2.21. |
Diabetes management device roadmap: Insulin delivery |
|
3.3. |
Insulin Pumps |
|
3.3.1. |
Insulin patch pumps |
|
3.3.2. |
Insulin pump market |
|
3.3.3. |
Insulin pump players and market share |
|
3.3.4. |
Key trends for the industry |
|
3.3.5. |
Accu-Chek Solo by Roche |
|
3.3.6. |
What do patch pumps offer over infusion pumps? |
|
3.3.7. |
Insulin pump technology roadmap |
|
3.4. |
Linking insulin pumps and CGM: Towards closed loop and the artificial pancreas |
|
3.4.1. |
Today: Hybrid closed loop systems |
|
3.4.2. |
The objective: Closing the feedback loop |
|
3.4.3. |
Medtronic leads development of hybrid closed-loop |
|
3.4.4. |
Insulet: Omnipod 5 |
|
3.4.5. |
Tidepool: Tidepool Loop |
|
3.4.6. |
Outlook for insulin pumps |
|
3.4.7. |
Conclusions for insulin delivery |
|
4. |
CARDIAC RHYTHM MONITORING SKIN PATCHES |
|
4.1.1. |
Cardiovascular disease (CVD) |
|
4.1.2. |
Atrial fibrillation and early detection |
|
4.1.3. |
Biopotential indicator and the electrocardiogram |
|
4.1.4. |
Diagnosis process for atrial fibrillation and other arrhythmias |
|
4.1.5. |
ECG monitor pain points that skin patches solve |
|
4.1.6. |
Cardiac monitoring skin patches: device types |
|
4.1.7. |
Cardiac monitoring device types - skin patches |
|
4.1.8. |
Cardiac rhythm monitoring skin patches: companies and product types |
|
4.1.9. |
Cardiac monitoring players and devices (1) |
|
4.1.10. |
Cardiac monitoring players and devices (2) |
|
4.1.11. |
How many ECG channels does a skin patch need? |
|
4.1.12. |
ECGs use wet electrodes and strong adhesives |
|
4.1.13. |
Dry electrodes may improve longer wear experience |
|
4.1.14. |
ECG skin patches are packaged with support AI |
|
4.1.15. |
Reimbursement codes for wearable cardiac monitors |
|
4.1.16. |
Wearable vs implantable monitoring |
|
4.1.17. |
Phillips (Biotelemetry) |
|
4.1.18. |
iRhythm |
|
4.1.19. |
Boston Scientific (Preventice Solutions) |
|
4.1.20. |
Conclusions for cardiac monitoring skin patches |
|
4.1.21. |
Cardiac rhythm monitoring skin patches: company profiles |
|
4.2. |
Fetal heart rate monitoring |
|
4.2.1. |
Fetal monitoring |
|
4.2.2. |
GE Healthcare (Monica Healthcare) |
|
4.2.3. |
Conclusions for fetal heart rate monitoring |
ページTOPに戻る
IDTechEx社のウエアラブル技術 - Wearable Technology分野での最新刊レポート
本レポートと同じKEY WORD（）の最新刊レポート
- 本レポートと同じKEY WORDの最新刊レポートはありません。
よくあるご質問
IDTechEx社はどのような調査会社ですか?
IDTechExはセンサ技術や3D印刷、電気自動車などの先端技術・材料市場を対象に広範かつ詳細な調査を行っています。データリソースはIDTechExの調査レポートおよび委託調査（個別調査）を取り扱う日... もっと見る
調査レポートの納品までの日数はどの程度ですか?
在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。
注文の手続きはどのようになっていますか?
1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。
お支払方法の方法はどのようになっていますか?
納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。
データリソース社はどのような会社ですか?
当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。
|
